FDA Approves Edwards’ Sapien 3 With The Alterra Prestent For Pulmonary Regurgitation
Executive Summary
The new device combines Edwards’ market-leading Sapien 3 transcatheter heart valve with its Alterra adaptive prestent device to treat patients with severe pulmonary regurgitation due to congenital valve defects.